Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes.
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes.
复制标题
DOI:
10.1016/j.jhin.2023.02.010
复制
发表时间:
2023-05
影响因子:
6.9
通讯作者:
Templeton, K.
中科院分区:
文献类型:
--
作者:
Cotton, S.;McHugh, M. P.;Dewar, R.;Haas, J. G.;Templeton, K.
The first epidemic wave of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Scotland resulted in high case numbers and mortality in care homes. In Lothian, over one-third of care homes reported an outbreak, while there was limited testing of hospital patients discharged to care homes. To investigate patients discharged from hospitals as a source of SARS-CoV-2 introduction into care homes during the first epidemic wave. A clinical review was performed for all patients discharges from hospitals to care homes from 1st March 2020 to 31st May 2020. Episodes were ruled out based on coronavirus disease 2019 (COVID-19) test history, clinical assessment at discharge, whole-genome sequencing (WGS) data and an infectious period of 14 days. Clinical samples were processed for WGS, and consensus genomes generated were used for analysis using Cluster Investigation and Virus Epidemiological Tool software. Patient timelines were obtained using electronic hospital records. In total, 787 patients discharged from hospitals to care homes were identified. Of these, 776 (99%) were ruled out for subsequent introduction of SARS-CoV-2 into care homes. However, for 10 episodes, the results were inconclusive as there was low genomic diversity in consensus genomes or no sequencing data were available. Only one discharge episode had a genomic, time and location link to positive cases during hospital admission, leading to 10 positive cases in their care home. The majority of patients discharged from hospitals were ruled out for introduction of SARS-CoV-2 into care homes, highlighting the importance of screening all new admissions when faced with a novel emerging virus and no available vaccine.
登录
查看更多内容
影响因子:
6.7
作者:
Burton JK;Reid M;Gribben C;Caldwell D;Clark DN;Hanlon P;Quinn TJ;Fischbacher C;Knight P;Guthrie B;McAllister DA
通讯作者:
McAllister DA
影响因子:
6.7
作者:
van den Besselaar JH;Sikkema RS;Koene FMHPA;van Buul LW;Oude Munnink BB;Frénay I;Witt RT;Koopmans MPG;Hertogh CMPM;Buurman BM
通讯作者:
Buurman BM
DOI:
10.1016/j.lanepe.2021.100038
发表时间:
2021-04
期刊:
The Lancet regional health. Europe
影响因子:
--
作者:
Jeffery-Smith A;Dun-Campbell K;Janarthanan R;Fok J;Crawley-Boevey E;Vusirikala A;Fernandez Ruiz De Olano E;Sanchez Perez M;Tang S;Rowland TA;Wynne-Evans E;Bell A;Patel B;Amin-Chowdhury Z;Aiano F;Paranthaman K;Ma T;Saavedra-Campos M;Ellis J;Lackenby A;Whitaker H;Myers R;Höschler K;Brown K;Ramsay ME;Shetty N;Chow JY;Ladhani S;Zambon M
通讯作者:
Zambon M
DOI:
10.1093/infdis/jiac348
发表时间:
2022-11-11
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
通讯作者:
--
影响因子:
33.9
作者:
Taylor, Joanne;Carter, Rosalind J.;Lynfield, Ruth
通讯作者:
Lynfield, Ruth